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Abstract
Objective:  to  determine  whether  C.  trachomatis  was  present  in  neonates  with  infection,  but
without  an  isolated  pathogen,  who  died  during  the  ﬁrst  week  of  life.
Methods: early  neonatal  death  cases  whose  causes  of  death  had  been  previously  adjudicated  by
the institutional  mortality  committee  were  randomly  selected.  End-point  and  real-time  poly-
merase  chain  reaction  of  the  C.  trachomatis  omp1  gene  was  used  to  blindly  identify  the  presence
of  chlamydial  DNA  in  the  parafﬁnized  samples  of  ﬁve  organs  (from  authorized  autopsies)  of
each  of  the  dead  neonates.  Additionally,  differential  diagnoses  were  conducted  by  amplifying
a  fragment  of  the  16S  rRNA  of  Mycoplasma  spp.
Results:  in  ﬁve  cases  (35.7%),  C.  trachomatis  DNA  was  found  in  one  or  more  organs.  Severe
neonatal infection  was  present  in  three  cases;  one  of  them  corresponded  to  genotype  D  of  C.
trachomatis.  Interestingly,  another  case  fulﬁlled  the  same  criteria  but  had  a  positive  polymerase
chain  reaction  for  Mycoplasma  hominis,  a  pathogen  known  to  produce  sepsis  in  newborns.
Conclusion: the  use  of  molecular  biology  techniques  in  these  cases  of  early  infant  mortality
demonstrated that  C.  trachomatis  could  play  a  role  in  the  development  of  severe  infection  and
in  early  neonatal  death,  similarly  to  that  observed  with  Mycoplasma  hominis.  Further  study  is
required  to  determine  the  pathogenesis  of  this  perinatal  infection.
© 2013  Sociedade  Brasileira  de  Pediatria.  Published  by  Elsevier  Editora  Ltda.  
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Relato  de  detecc¸ão  de  DNA  de  Chlamydia  trachomatis  em  tecidos  de  casos  de  óbito
neonatal
Resumo
Objetivo:  determinar  se  a  C.  trachomatis  está  presente  em  neonatos  com  infecc¸ão,  porém  sem
patógeno  isolado,  que  morreram  durante  a  primeira  semana  de  vida.
Métodos: casos  de  óbito  neonatal  precoce  cujas  causas  de  óbito  haviam  sido  anteriormente
determinadas pelo  Comitê  de  Mortalidade  da  instituic¸ão  foram  aleatoriamente  selecionados.
Foram utilizadas  as  reac¸ões  em  cadeia  da  polimerase  convencional  e  em  tempo  real  do  gene
omp1  da  C.  trachomatis,  para  identiﬁcar,  às  cegas,  a  presenc¸a de  DNA  de  clamídia  nas  amostras
desparaﬁnizadas  de  cinco  órgãos  (de  autópsias  autorizadas)  de  cada  um  dos  neonatos  mortos.
Além  disso,  foram  realizados  diagnósticos  diferenciais  por  ampliﬁcac¸ão  de  um  fragmento  do
rRNA  16S  de  Mycoplasma  ssp.
Resultados:  em  cinco  casos  (35,7%)  a  presenc¸a de  DNA  de  C.  trachomatis  foi  detectada  em
um ou  mais  órgãos.  Havia  infecc¸ão  neonatal  grave  em  três  casos;  um  deles  correspondente  ao
genótipo  D  de  C.  trachomatis.  Curiosamente,  outro  caso  preencheu  os  mesmos  critérios,  porém
possuía  uma  reac¸ão  em  cadeia  da  polimerase  positiva  para  Mycoplasma  hominis,  um  patógeno
conhecido  por  causar  sepse  em  recém-nascidos.
Conclusão:  a  utilizac¸ão  de  técnicas  de  biologia  molecular  nos  casos  de  mortalidade  infantil
precoce mostrou  que  a  C.  trachomatis  poderia  desempenhar  um  papel  no  desenvolvimento  de
infecc¸ão  grave  e  no  óbito  neonatal  precoce  semelhante  ao  observado  com  a  Mycoplasma  homi-
nis.  São  necessários  estudos  adicionais  para  determinar  a  patogênese  dessa  infecc¸ão  perinatal.
©  2013  Sociedade  Brasileira  de  Pediatria.  Publicado  por  Elsevier  Editora  Ltda.  
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Neonatal  mortality  has  been  deﬁned  as  mortality  occur-
ring during  the  ﬁrst  28  days  of  life.  It  is  mostly  associated
to infections  that  are  either  congenital  or  acquired  after
birth. These  infections  strongly  impact  the  causes  of  death
and abortion  in  non-industrialized  countries.1,2 Chlamydia
trachomatis is  the  cause  of  the  most  sexually  transmitted
bacterial infection  worldwide.3 The  prevalence  C.  tra-
chomatis infection  during  pregnancy  is  variable:  in  the
United States,  it  is  between  2%  and  13.7%;  in  Brazil,
between 2.7%  and  10%,4 and  in  Mexico,  between  4%  and
28%.5 It  is  related  to  premature  rupture  of  membranes,
chorioamnionitis,  premature  birth,  and  the  development  of
neonatal ophthalmitis  and  pneumonitis.  It  has  also  been
related to  high  rates  of  low  birth  weight  and  perina-
tal mortality.4 Variable  clinical  manifestations  have  been
observed, including  staccato  cough,  prodromal  rhinorrhea,
and history  of  conjunctivitis,  tachypnea,  and  fever.  The
most frequent  ﬁndings  in  chest  radiographies  are  intersti-
tial inﬁltration  of  bilateral  lung  ﬁelds,  hyperinﬂation,  and
atelectasis.6
The  risk  for  vertical  transmission  of  C.  trachomatis  is
between 60%  and  70%,  and  occurs  during  the  infant’s  passage
through the  birth  canal;  however,  there  is  some  evidence
that vertical  transmission  can  also  occur  in  utero,  since  new-
borns delivered  by  cesarean  sections  have  also  been  born
infected and  with  intact  membranes.6--9
Recently,  Rours  et  al.10 demonstrated  the  presence  of
chlamydial DNA  in  the  placenta  of  pre-term  products,  and
found an  association  of  the  DNA  with  the  degree  and
progress of  tissue  inﬂammation.  Currently,  there  is  no  good
experimental model  available  for  the  effects  of  Chlamydia
C
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wnfections  during  pregnancy  and  its  association  with  neona-
al death.
Aside from  the  pulmonary  and  conjunctive  tissues  of
ewborns, Chlamydia  has  also  been  found  in  intestinal,  gen-
tourinary, myocardial,  and  nervous  system  tissues.11--13 The
resence of  Chlamydia  in  these  other  tissues  suggests  that  it
as an  invasive  capacity.  The  present  study  aimed  to  detect
hlamydial DNA  in  different  tissues  of  neonates  who  were
iagnosed with  ‘‘infection  without  an  isolated  pathogen’’
nd died  during  the  ﬁrst  week  of  life.  Neonates  whose
vident cause  of  death  was  not  infectious  were  also  stud-
ed. Additionally,  it  was  sought  to  identify  the  Chlamydia
enotypes involved  in  these  neonates  who  developed  early
nfection.
ethods
thics  statement
his  study’s  protocol  was  reviewed  and  approved  by  the
nstitutional Ethics  Committee  of  the  School  Medicine  at  the
ational Polytechnic  Institute,  in  Mexico  City,  Mexico.
eﬁnitions
nfection
evere  neonatal  infection  was  established  by:  a)  ﬁnding  of
. trachomatis  omp1  gene  fragments  in  two  or  more  dif-
erent organs;  b)  clinical  and  laboratory  data  consistent
ith infection  in  the  neonate  during  his  lifetime;  c)  mother
ith antecedents  of  infection  risk;  and  d)  histopathological
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iagnosis  of  placental  chorioamnionitis  and  pneumonitis  in
he cadaver.
reterm  rupture  of  membranes  (PROM).  Rupture  of  the
etal membranes  prior  to  the  onset  of  labor,  regardless  of
estational age.14
arly  neonatal  death.  Death  occurring  before  the  seventh
ay of  extrauterine  life.15
nclusion  criteria
he  inclusion  criteria  were:  availability  of  all  selected
rgans, samples,  and  reports;  updated  analysis  by  the  peri-
atal mortality  committee  with  ﬁnal  dictum;  and  complete
ecords.
election  of  autopsy  samples
 random  selection  of  20%  of  the  cases  of  early  neona-
al deaths  that  occurred  between  January  1  and  December
1, 2003  and  fulﬁlled  the  inclusion  criteria  was  performed.
ases were  separated  into  two  groups  according  to  the
udgment or  ﬁnal  diagnosis  of  the  institution’s  perinatal  mor-
ality committee.  Group  1  consisted  of  cases  of  death  due  to
ystemic infection16 without  pathogen  identiﬁcation.  Group
 was  formed  by  cases  of  death  due  to  another  cause  that
as not  related  with  infection.
The  autopsy  organs,  speciﬁcally  lungs,  kidneys,  brain,
iver, and  bronchi,  which  were  embedded  in  parafﬁn  blocks
or all  participating  cases,  were  located.  The  study  included
nly cases  that  had  all  these  organs  available,  as  well
s complete  maternal  and  neonatal  clinical  records  and
istopathological studies  of  the  autopsy  and  placenta.  The
athologist in  chief  blindly  restudied  the  histologic  samples
rom the  cadavers.
Placentas are  usually  routinely  analyzed:  hematoxylin
nd eosin--stained  histologic  sections  are  investigated  for
eciduitis, vasculitis,  endometritis,  or  chorioamnionitis
ithout special  studies.  Later,  the  entire  material  is  dis-
arded. For  this  reason,  only  the  results  of  the  single  study
f the  placenta  were  included.
The  rest  of  the  plates  was  deparafﬁnized  and  processed
or DNA  extraction.  All  tests  were  performed  in  a  blinded
anner. Clinical  and  demographic  data  were  obtained  from
ospital records.
NA  extraction
issue  samples  were  deparafﬁnized  with  xylene  at  room
emperature and  washed  with  ethanol.  The  obtained  tis-
ue was  then  treated  with  proteinase  K,  and  the  DNA  was
btained by  the  phenol-chloroform-isoamyl  technique  and
thanol precipitation  as  previously  described.17
hlamydia  trachomatis  detection
nd-point  polymerase  chain  reaction  and  real-time  poly-
erase chain  reaction  were  performed  using  PTC-100
ystem (MJ  Research,  Inc.  -  Waltham,  MA,  United  States)
nd StepOne  (Applied  Biosystems  -  Carlsbad,  CA,  United
tates), respectively.  The  primers  used  for  end-point
a
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olymerase  chain  reaction  are  those  proposed  by  Dutilh
t al.18 and  amplify  a  fragment  of  the  omp1  gene  of
. trachomatis  (5’-GCCGCTTTGAGT  TCTGCTTCCTC-3’;  5’-
CAAGTGGTGCA  AGGATCGCA-3’).
Each  end-point  polymerase  chain  reaction  contained  1.75
M MgCl2, 0.2  mM  dNTPs,  25  pM  of  each  proposed  primer,  2.5
 Taq  polymerase  (GoTaq® Flexi  DNA  polymerase  Promega© -
adison, WI,  United  States),  and  5  L  of  the  DNA  sample,  for
 ﬁnal  volume  of  25  L.  The  reaction  mixture  was  incubated
or 5  min  at  95 ◦C,  followed  by  35  cycles  of  1  min  at  95 ◦C  for
enaturation, 1  min  at  59 ◦C  for  alignment,  1  min  at  70 ◦C
or extension,  and  a  ﬁnal  elongation  step  of  5  min  at  70 ◦C.
he sample  was  considered  positive  when  an  ampliﬁcation
roduct of  129  bp  was  obtained.
The  real-time  polymerase  chain  reaction  was  performed
sing 3 mM  of  2.7  mM  MgCl2,  25  pM  of  each  of  the
roposed primers,  2.5  U  Taq  polymerase  (Applied  Biosys-
ems), and  5  L  of  the  DNA  sample,  for  a  ﬁnal  volume
f 25  L.  The  primers  used  were  designed  by  Primer
xpress 3.0  Sequence  program  (Applied  Biosystems),  the
mpliﬁed region  is  inside  the  same  amplicon  of  129  bp
btained with  Dutilh’s  primers  Fw:  5’-CCTGCTGAACCAAGC
TTATG-3’  and  Rv:  5’-AGGATCTC  CGCCGAAACC-3’;  probe:
’-TCGACGGAATTC TGT-3’.  The  reaction  mixture  was  pre-
eated at  95 ◦C  for  20  s,  followed  by  40  cycles  of  30  s  at
5 ◦C,  20  s  at  60 ◦C,  and  20  s  at  72 ◦C.
mpliﬁcation  and  detection  of  Mycoplasma  spp.  for
ifferential diagnoses
nd-point  polymerase  chain  reaction  was  performed  accord-
ng to  the  protocol  proposed  by  van  Kuppeveld  et  al.19 The
rimers used  were:  MGSO:  5’-GCACCATCTGTCACTCTGTTA
CCTC-3’  and  GPO-1:  5’-ACTCCTACGGGAGGCAGCAGTA-3’.
ach  polymerase  chain  reaction  contained  20  pM/L
rimers, 10  uM/L  dNTPs,  2  mM/L  MgCl2, 5  U/L  Taq  poly-
erase, 3  L  DNA,  and  43  L water,  for  a  ﬁnal  volume  of
0 L.  The  reaction  mixture  was  incubated  at  94 ◦C  for  5  min,
ollowed by  35  cycles  of  denaturing  at  94 ◦C  for  1  min,  align-
ent at  60 ◦C  for  1  min,  extension  at  72 ◦C  for  1  min,  and  a
nal extension  at  72 ◦C  for  5  min.  A  sample  was  considered
ositive if  a  715  bp  product  was  ampliﬁed.
To  detect  the  species,  the  following  primers  were
sed with  the  same  polymerase  chain  reaction  protocol:
ychomp (5’-ATACATGCATGTCGAGCGAG-3’)  and  Mychomn
5’-CATCTT TTAGTGGCGCCTTAC-3’).  Additionally,  M.  homi-
is  was  detected  according  to  Grau  et  al.20 and  U.
realyticum was  detected  according  to  Blanchard  et  al.21
ith  the  primers  U5  (5’-CAATCT  GCTCGTGAAGTATTAC-3’)
nd U4  (5’-ACGACGTC  CATAAGCAACT-3’).
nalysis  of  restriction  fragment  length
olymorphism
 restriction  fragment  length  polymorphism  (RFLP)  anal-
sis was  performed  using  a  previously  described  method5
o  genotype  the  samples  with  129  bp  amplicons.  Brieﬂy,
 1,142  bp  fragment  of  the  C.  trachomatis  omp1gene
as ampliﬁed.  The  primers  used  for  the  ampliﬁcation
ere the  same  as  those  reported  by  Yang  et  al.:22
MP1  (5’-GCCGCTTTG  AGTTCTGCTTCCTC-3’)  and  OMP2
185
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Figure  2  Restriction  fragment  length  polymorphism.  omp1  of
Chlamydia trachomatis  genotype  D.  Sample:  liver  from  case  1.
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(5’-ATTTACGTGAGCAGCTCTCTCAT-3’).  Samples  positive  for
the 1,142  bp  amplicon  were  subjected  to  a  second
polymerase chain  reaction  that  generated  an  879  bp  frag-
ment. The  primers  used  were  also  described  by  Yang
et al.:22 P3  (5’-TGACTTTGTTTTCGA  CCGTGTTTT-3’)  and
P4 (5’-TTTTCTAGATTTCATCTTGTTCAAT/CTG-3’).  The  879  bp
fragment was  then  incubated  with  the  endonuclease  Alu1
(Invitrogen, Applied  Biosystems)  for  10  h  at  37 ◦C.  The
resulting band  pattern  was  compared  with  that  of  the  cor-
responding type  strain.  In  this  study,  that  was  uW-3Cx  (ATCC
VR-885D).
Results
Of  the  73  cases  available,  18  were  chosen  at  random.  How-
ever, it  was  not  possible  to  locate  all  the  organs  of  interest  in
three cases,  and  the  placenta  study  results  were  not  avail-
able for  one  case.  Table  1  depicts  results  of  the  14  infant
mortality cases  studied,  the  perinatal  characteristics  of  the
newborns, and  the  most  relevant  maternal  data.  Four  cases
fulﬁlled all  of  the  infection  or  neonatal  systemic  infection
criteria (cases  1,  3,  4,  and  8).  Cases  1  and  8  were  nega-
tive for  bacterial  and  fungal  cultures  performed  both  during
their life  or  postmortem.  On  the  ﬁrst  day  of  life  for  case
3, Staphylococcus  haemolyticus  was  isolated  through  blood
culture. In  case  4,  the  newborn  lived  only  one  hour,  and  the
corresponding microbiological  cultures  were  not  performed.
The  intentional  search  for  DNA  from  Mycoplasma  and
Chlamydia in  postmortem  tissues  using  polymerase  chain
reaction resulted  in  ampliﬁcation  of  the  129  bp  C.  tracho-
matis omp1  gene  in  ﬁve  neonates.  It  was  ampliﬁed  in  two
or more  organs  for  cases  1,  2,  3,  and  4,  and  only  in  the  kid-
ney for  case  6.  In  case  8,  a  715  bp  product,  corresponding  to
Mycoplasma, was  ampliﬁed  in  lung  and  kidney  tissues  (image
not shown).
Chlamydial DNA  was  found  in  tissues  of  cases  2  and
6, but  with  no  clinical  or  histopathological  correlation
indicating infection.  These  cases  only  presented  with
prematurity, barotrauma,  and  pulmonary  hemorrhage.  Addi-
tionally, ampliﬁcation  of  1,142  bp  and  879  bp  fragments  for
RFLP analysis  of  samples  positive  for  chlamydial  DNA  was
only achieved  for  cases  1,  3,  and  4  (Fig.  1).  The  RFLP  analysis
of the  samples  where  ampliﬁcation  of  the  879  bp  fragment
was achieved  only  allowed  for  the  identiﬁcation  of  genotype
Molecular
weight
marker 
 C–   C+ P250 
case 5case 4case 1case 3case 1case 3
L191 L185 K187 P185 Br187 
800 pb
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Figure  1  PCR  or  Polymerase  chain  reaction  CR  omp1  gene  of
Chlamydia trachomatis  879  bp  fragment.  Deparafﬁnized  sam-
ples of  organs  from  autopsy.  L  =  liver,  P  =  lungs,  K  =  kidneys,
Br =  brain,C−  =  Negative  control,  C+  =  Positive  control  (Numbers
belong to  the  institutional  classiﬁcation  of  cases).
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bype  strain:  Chlamydia  trachomatis  UW-3/Cx  (ATCC  VR  885D).
roduct of  879  bp  was  restricted  with  Alu  I.  M,  Molecular  weight
arker.
 of  C.  trachomatis  (case  1;  Fig.  2).  In  cases  2  and  6,  it  was
ot possible  to  amplify  the  1,142  bp  fragment,  and  the  pres-
nce of  chlamydial  DNA  was  conﬁrmed  in  liver  tissue  through
eal-time polymerase  chain  reaction  only  for  case  2  (image
ot shown).
All cases  were  endotracheally  intubated  and  received
entilatory assistance  during  their  entire  life.  Six  cases  of
remature membrane  rupture  were  found.  Of  these,  two
eonates (cases  1  and  3)  had  evidence  of  chlamydial  DNA
nd remained  in  utero  with  ruptured  membranes  for  8  and
 days,  respectively.  The  clinical  characteristics  of  all  cases
re shown  in  Table  2.
The  causes  of  death  in  the  remaining  cases  (cases  5  to  7
nd 9  to  14)  were  not  associated  with  infection.  Four  (29%)
ied due  to  causes  related  with  their  premature  birth,  three
21%) due  to  structural  congenital  defects  not  compatible
ith life,  one  due  to  hydrops  fetalis  of  non-immunological
rigin with  severe  preeclampsia,  and  one  due  to  maternal-
etal isoimmunization  to  Rh.  All  these  cases  had  negative
olymerase chain  reaction  results  for  C.  trachomatis  and
ycoplasma spp.,  with  the  exception  of  case  6,  previously
entioned.
iscussion
evere  infections  are  still  the  main  cause  of  neonatal  mor-
idity and  mortality  in  developing  regions.  Three-fourths  of
nfant mortality  cases  occur  during  the  ﬁrst  week  of  life,  and
n many  cases,  the  cause  of  death  remains  unknown.23
Chlamydial  infection  in  the  perinatal  and  neonatal  stage
an cause  many  diseases.  These  include  conjunctivitis,
asopharyngitis,  pneumonitis,  and  less  frequently,  rhinitis,
iddle ear  otitis,  myocarditis,  and  encephalitis.4 How-
ver, the  discovery  of  genetic  residues  of  this  intracellular
acterium in  organic  tissues  is  quite  rare  in  the  medical
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Table  1  Clinical  and  pathological  correlations  and  outcomes  of  Chlamydia  trachomatis  (omp1)  PCR  in  deparafﬁnized  samples  of  brain,  liver,  kidney,  lung,  and  bronchus.  Early
neonatal deaths.
Case  Maternal  risk  factor  Autopsy  diagnosis  Placental
diagnosis
Bacterial  cultures
outcomes
PCR Previous  diagnosisa New  diagnosis
1  PROM  eight  days  Congenital  pneumonia  Chorioamnionitis  All  negative  C.  trachomatis
in liver,  brain,
and bronchus
Neonatal  sepsis  UEA  Infection  by  C.
trachomatis
2 Preterm  delivery.
Previous  stillbirth
Moderate  pneumothorax,
40% atelectasis
Normal  CSF  PM  P  rettgeri  +  E
gergoviae
C. trachomatis
in liver  and
brain and
real-time  PCR
in liver
Pneumothorax  Probable  infection  by
C. trachomatis
3  PROM  six  days  Acute  pneumonia,  hyaline
membrane
Chorioamnionitis  First  day:
hemoculture  S
haemolyticus
C. trachomatis
in liver,  kidney
and brain
Neonatal  sepsis  UEA  Infection  by  C.
trachomatis
Third day:  CSF  and
hemoculture negative
4 PROM  26  h
Previous  tubal
obstruction,  abortion,
and  stillbirth
Severe congenital
pneumonia
Necrotizing
chorioamnionitis.
Funisitis
NM  C.  trachomatis
in liver  and
bronchus
Neonatal  sepsis  UEA  Infection  by  C.
trachomatis
5 Previous  abortion  Multiple  major  structural
defects
Small  All  negative  All  negative  Multiple  congenital  structural
defects
Multiple congenital
structural  defects
6 None  Renal  right  agenesis
Pulmonary hemorrhage
Normal  NM  C.  trachomatis
in kidney
Surfactant  pulmonary
hemorrhage
Complications  of
prematurity
7 PROM  26  h  33%  Hyaline  membrane
70% atelectasis
Normal  All  negative  All  negative  Hyaline  membrane  Pulmonary
hypertension
Complications  of
prematurity
8 PROM  8  h  Congenital  pneumonia  Severe
chorioamnionitis
and  funisitis
All negative  Mycoplasma
hominis  in  lung
and kidney
Congenital  neonatal  sepsis
UEA
Infection by
Mycoplasma  hominis
9 No  Hydrops  fetalis  Signs  of  hypoxia  Hemoculture:
Staphylococcus  spp.
All the  other  negative
All  negative  Nonimmune  Hydrops  fetalis  Nonimmune  Hydrops
fetalis
10 Previous  abortion  Immaturity  systemic  Normal  NM  All  negative  Immaturity  Obstetric  trauma  Extreme  prematurity
11 Two  previous  stillbirth
and  an  infant  death
Erythroblastosis.  Pulmonary
emphysema
Erythroblastosis  All  negative  All  negative  Hydrops  fetalis  from  Rh
isoimmunization
Hydrops fetalis  from
Rh isoimmunization
12  PROM  1  h  Multiple  major  structural
defects
Normal  All  negative  All  negative  Multiple  major  structural
defects
Multiple major
structural  defects
13 None  Immaturity  Mild  subchorionitis
and deciduitis
NM All  negative  Immaturity  Extreme  prematurity
14 An  infant  death  Thanatophoric  dysplasia  Normal  NM  All  negative  Severe  bone  dysplasia  Severe  bone  dysplasia
CSF, Cerebrospinal ﬂuid; CT, Chlamydia trachomatis; NM, not made; PCR, polymerase chain reaction; PM, post-mortem; PROM, Preterm Rupture of Membranes (18); UEA, unknown etiologic
agent.
a Determined by the Perinatal Mortality Committee.
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Table  2  Clinical  characteristics  (mother  and  child)  of  the  infant  mortality  cases.
Case  1 Case 2 Case  3 Case  4 Case  5 Case 6 Case  7 Case  8 Case  9 Case 10 Case  11 Case  12 Case  13 Case  14
Age  3d  7h
12m
42m 2d  1h
47m
1h  2m 5d  20h
5m
3h 1m 1d  20h
48m
1d  12h
46m
1d 2h
45m
20m 18h  5d  19m 41m  1h  20m
Maternal age  (years) 33 28  30  35  26  26  15  23  36  23  30  27  18  23
Duration of  PROM 8d 0  6d  26h  0  0  1d  2h 8h  0  0  0  1h  0  0
Delivery C  C  C  ED  C  C  C  ED  C  ED  C  C  ED  DD
Gender Male  Male  Male  Female  Male  Male  Female  Female  Female  Female  Male  Male  Female  Female
Apgar 1  and  5  minutes  2-5  5-4  3-7  1-2  7-8  4-7  4-9  4-8  4-8  0-1  3-7  8-9  1-1  1-1
Weight (g)  590  1,050  740  710  2,000  910  1,840  750  850  520  1,290  2,350  890  1,480
Height (cm)  29  37  33  34  44  33  43  36  31.5  30  38  45  34  32
Gestational age  (weeks)  25  29  27  26  41  26  32  25  27  25  27  32  25  31
Maternal diagnostic  Hyp  PD  PROM  Ch  PROM  Ch  IGR  UTI  Ch  PROM  PROM
Ch
Severe
Pre-
eclam
PD UTI  Isoimm  Hydrops
fetalis
PD  PD
Neonatal antibiotic
treatment
Ampi
Amika
- Ampi
Amika
-  -  -  Ampi
Amika
Ampi
Amika
- - Dicloxa
Amika
-  -  -
Growth for  gestational
age
SGA  AGA  SGA  AGA  SGA  AGA  AGA  AGA  AGA  SGA  AGA  LGE  AGA  AGA
AGA, appropriate for gestational age; Amika, amikacin; Ampi, ampicillin; C, Cesarean section; Ch, chorioamnionitis; d, days; DD, dystocic delivery; Dicloxa, dicloxacillin; ED, eutocic
delivery; h, hours; Hyp, hypothyroidism; IGR, intrauterine growth retardation; Isoimm, isoimmunization; LGE, large for gestational age; m, minutes; PD, preterm delivery; Pre-eclam,
pre-eclampsia; PROM, premature rupture of membranes; SGA, small for gestational age; UTI, urinary tract infection.
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polymerase chain  reaction  and  identiﬁcation  in  one  case88  
iterature.24 In  this  study,  chlamydial  DNA  was  found  in
ore than  two  organs  in  four  cases  (cases  1,  2,  3,  and  4),
hich suggest  the  potential  for  a  multivisceral  infection  by
his pathogen.  One  notable  instance  was  case  2  where  the
eonate was  born  prematurely  by  cesarean  and  died  due  to
xtensive pneumothorax.  Case  2  did  not  have  histopatholog-
cal data  for  inﬂammation  in  the  lungs  or  placenta;  however,
he repeated  ﬁnding  of  chlamydial  DNA  in  the  brain  and
iver of  this  newborn  presents  a  strong  suspicion  of  systemic
nfection by  C.  trachomatis.  Due  to  the  lack  of  determina-
ion of  histopathological  criteria,  this  case  suggests  that  the
ntire spectrum  of  C.  trachomatis  pathogenesis  is  still  not
ompletely known.
At  no  moment  were  diagnostic  studies  performed
egarding Chlamydia  or  Mycoplasma  infection  in  these
atients, probably  due  to  their  short  lifespan.  Likewise,  the
others were  also  not  screened  for  atypical  pathogens  dur-
ng their  pregnancy.  The  lack  of  C.  trachomatis  infection
tudies in  these  women  was  probably  due  to  poor  or  no  pre-
atal care:  six  (43%)  women  had  no  prenatal  care,  ﬁve  (36%)
ad only  two  or  three  consultations,  and  three  (21%)  had  ﬁve
r six  prenatal  medical  consultations.
The  cause  of  death  for  case  8  was  a  systemic  infection
y Mycoplasma  hominis.  This  pathogen  has  been  shown  to
roduce severe  infection  in  fetuses  and  newborns,  and  can
e  vertically  transmitted.  Among  the  infections  caused  by
ycoplasma hominis,  pneumonia,  which  evolves  rapidly  to
ronchopulmonary dysplasia,  and  systemic  infections  with
oor prognoses  if  not  detected  and  treated  in  time25 stand
ut. This  situation  could  also  occur  with  the  infections
aused by  C.  trachomatis.
The  polymerase  chain  reaction  is  the  most  sensitive  and
apid method  to  detect  microbial  pathogens  in  clinical  spec-
mens, particularly,  for  Chlamydia  and  Mycoplasma,  which
re difﬁcult  to  culture  in  vitro.  The  application  of  this
ethod to  clinical  specimens  has  many  potential  pitfalls  due
o the  presence  of  inhibitors  and  contamination.  Further,
he sensitivity  and  speciﬁcity  of  this  assay  is  depend-
nt on  target  genes,  primer  sequences,  techniques  used,
NA extraction  procedures,  and  ampliﬁed  product  detec-
ion methods.  However,  the  present  investigation  group
ad previously  standardized  the  polymerase  chain  reaction
pplied in  this  study.24 Additionally,  the  positive  samples
n the  assay  were  conﬁrmed  through  real-time  polymerase
hain reaction,  a  method  that  offers  many  general  techni-
al advantages,  including  reduced  probabilities  of  variability
nd contamination,  online  monitoring,  and  no  requirement
or post-reaction  analyses.
The  current  capacity  to  detect  infections  such  as  C.
rachomatis, Mycoplasma,  and  Ureaplasma  (infections  that
mpact the  health  of  the  most  vulnerable  populations:  new-
orns and  pregnant  women),  will  allow  for  the  identiﬁcation
f the  high  frequency  by  which  these  microorganisms  pro-
uce membrane  ruptures,  premature  births,  and  neonatal
isease that  can  become  severe  and  even  fatal.6 Therefore,
t is  believed  that,  in  the  future,  it  will  be  necessary  to
eassess the  public  policies  on  prenatal  care.
Five  of  14  cases  in  this  series  received  empirical  antimi-
robial treatment.  The  antibiotic  scheme  administered  to
wo of  the  newborns  that  died  with  systemic  infections
y C.  trachomatis  (cases  1  and  3)  consisted  of  an  amino-
lycoside and  a  beta-lactam,  treatment  that  is  usually
o
c
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sed  when  there  is  suspicion  of  congenital  infection,  since
t covers  almost  all  etiological  possibilities  of  neonatal
nfection acquired  in  utero.26 However,  the  Chlamydia  and
ycoplasma genera  are  not  included  in  their  antimicrobial
pectrum.27 Ocular  prophylaxis  can  fail  to  prevent  neonatal
hlamydial conjunctivitis,  and  does  not  prevent  coloniza-
ion or  infection  in  the  lungs;  the  only  means  of  preventing
hlamydial infection  in  the  newborn  is  treating  the  infected
other.
Case 1  did  not  have  bacterial  or  fungal  development  in
he performed  cultures,  and  case  2  was  classiﬁed  as  contam-
nated because  the  cerebrospinal  ﬂuid  sample  was  obtained
ostmortem and  developed  the  polymicrobial  species  Prov-
dencia rettgeri  and  Enterobacter  gergoviae,  which  are
ot known  as  producers  of  neonatal  infections.  Case  3
as delivered  by  cesarean  section  with  six  days  of  prema-
ure membrane  rupture  and  maternal  chorioamnionitis.  At
irth, a  sample  of  umbilical  cord  blood  was  obtained  for
ulture, which  showed  the  development  of  Staphylococ-
us haemolyticus.  This  bacterium  is  part  of  the  cutaneous
ora and  is  not  a  pathogen  that  produces  congenital  neona-
al infections.28 Additionally,  treatment  with  ampicillin
nd amikacin  does  not  cover  Staphylococcus  haemolyticus,
hich is  characteristically  multiresistant.  These  premises
upport the  conclusion  that  those  samples  were  contami-
ated.
The serotypes  of  C.  trachomatis  with  high  invasive  capac-
ty can  invade  diverse  tissues  of  adult  individuals  and  cause
ymphogranuloma (L1,  L2,  L2a,  and  L3).  In  this  study,  it  was
hown that  the  C.  trachomatis  infection  in  case  1  was  due  to
enotype D,  which  is  one  of  the  highest  prevalence  serotypes
orldwide in  genitourinary  infections  of  the  sexually  active
opulation.27 Genotype  D  is  one  of  the  few  C.  trachomatis
erotypes with  a  cytotoxin  that  has  great  homology  to  the
amily of  large  cytoxins  (LCTs)  produced  by  Clostridium  dif-
cile. These  LCTs  cause  diverse  cytopathic  effects  in  their
ost cells  because  their  glucosyltransferase  activity  modi-
es the  intracellular  regulatory  molecules  such  as  the  GTP
inding molecule  of  the  Ras  superfamily.29 Additionally,  LCTs
enerally  interfere  with  the  organization  and  dynamics  of
ctin in  both  the  cytoskeleton  and  intracellular  trafﬁcking.30
he  cytopathic  effect  produced  by  the  cytotoxin  of  C.  tra-
homatis serotype  D  results  in  the  rounding  of  infected  cells
ue to  depolymerization  of  actin.  This  could  help  explain,  in
art, the  capacity  of  serotype  D  to  infect  and  disseminate  to
iverse organs  in  those  newborns  in  whom  chlamydial  DNA
as found.  However,  the  mechanisms  through  which  C.  tra-
homatis  infection  is  disseminated  to  different  organs  are
et to  be  identiﬁed.
This study  presented  the  possibility  of  infection  by  C.
rachomatis to  various  organs  of  fetuses  and  newborns,  and
hat this  might  have  been  associated  with  infant  mortality.
owever, further  studies  are  needed  to  conﬁrm  this  ﬁnding.
The  ﬁnding  of  chlamydial  DNA  in  more  than  one  organ  of
utopsy may  not  be  the  most  accepted  way  for  diagnosing
ystemic infection  or  establishing  cause  of  death.  However,
n the  authors’  opinion,  the  discovery  of  three  different
. trachomatis  DNA  sequences  by  end-point  and  real-timef the  C.  trachomatis  genotype  involved  provides  sufﬁ-
ient evidence  for  further  investigations  using  additional
nd improved  resources.  Immunohistochemistry  would
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strengthen  the  evidence  presented  here,  but  unfortunately,
immunohistochemical  stains  were  not  performed  in  the
present samples.
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